An experimental drug shrank tumors in patients with a variety of cancers sharing the same genetic defect, new studies found, part of a push in oncology research to treat tumors by their molecular traits regardless of where they are in the body.
from WSJ.com: US Business http://ift.tt/2qLsLm6
via IFTTT
No comments:
Post a Comment